Localized swelling, mass and lump of skin and subcutaneous tissue

MESH PheWeb

R18_LOCALIZED_SWELL_MASS_LUMP_SKIN_SUBCU_TISSUE

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 R22

Cause of death: ICD-10 R22

7719

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10 ; C.O.D: 10

7719

Check minimum number of events None

7719

Include endpoints None

7719

R18_LOCALIZED_SWELL_MASS_LUMP_SKIN_SUBCU_TISSUE

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF4

Parent code in ICD-10 R2[0-3]

Name in latin Intumescentia localis, massa sive nodus cutis sive telae subcutaneae

Similar endpoints

↥

List of similar endpoints to Localized swelling, mass and lump of skin and subcutaneous tissue based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

All

Female

Male

Number of individuals

7430

4231

3199

Unadjusted prevalence (%)

2.41

2.44

2.37

Mean age at first event (years)

55.32

52.76

58.70

?

Follow-up

Amount of time to look for the endpoint since entering the study. This is either either 1, 5, 15 years or the full study time from 1998 to 2019.

Absolute risk

Estimates the probability of dying from the current endpoint. Check the Documentation page for Mortality: absolute risk to get more details.

Hazard Ratio (HR) and 95% Confidence Interval (CI)

Measures how much the risk of dying increases (HR > 1) or decreases (HR < 1).

Number of individuals (N)

Number of individuals having the current endpoint and died during the follow-up time.
Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.04	3.56 [2.67, 4.76]	7.5e-18	558
15 years	0.01	1.59 [1.21, 2.09]	8.1e-4	212
5 years	0.00	4.00 [3.16, 5.06]	8.2e-31	202
1 year	0.00	10.07 [7.77, 13.04]	1.3e-68	109

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: R18_LOCALIZED_SWELL_MASS_LUMP_SKIN_SUBCU_TISSUE – Localized swelling, mass and lump of skin and subcutaneous tissue
GWS hits:

Survival analyses between endpoints

↥

Plot

before Localized swelling, mass and lump of skin and subcutaneous tissue
after Localized swelling, mass and lump of skin and subcutaneous tissue

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Localized swelling, mass and lump of skin and subcutaneous tissue

↥